Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Respimat add-on therapy in adolescents with severe persistent asthma
2010-021778-13Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tiotropium in asthma and severe asthma (3 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Peak FEV1 response within 3 hours post dosing at week 12. Started Nov 2010; status: completed.
02
Drugs
tiotropium
03
Conditions
asthmasevere asthma
Beyond the preview
Go deeper on 2010-021778-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021778-13.